Microinvasive squamous cell carcinoma of the cervix: immunohistochemically detected prognostic factors in a case with poor clinical outcome

被引:3
作者
Kohlberger, P
Edwards, L
Hacker, NF
机构
[1] Univ Vienna, Sch Med, Dept Obstet & Gynaecol, A-1090 Vienna, Austria
[2] Prince Wales Hosp, Dept Gynaecol, Randwick, NSW 2031, Australia
[3] Royal Hosp Women, Gynaecol Canc Ctr, Sydney, NSW, Australia
[4] Univ New S Wales, Sydney, NSW, Australia
关键词
immunohistochemistry; microinvasive cervical cancer; prognosis;
D O I
10.1016/S0090-8258(03)00250-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background. Established prognostic factors for cervical cancer are tumor stage, vascular space invasion, tumor size/volume, depth of invasion, and lymph node status. Although patients with superficially invasive lesions have a very good prognosis, cases are still reported which have a poor clinical outcome. Case. We report a case of a 41-year-old woman with very early stromal invasion (0.6 mm deep and <1 mm wide) who presented with a pelvic recurrence at 3 years and then developed an anterior abdominal wall and disseminated peritoneal recurrence 4 years after extrafascial hysterectomy. Archival tissue of the cone biopsy was stained immunohistochemically for CD44v6, Her2-neu, p53, bcl-2, MMP-1 and VEGF and showed positive staining for CD44v6 and MMP-1. Conclusion. The identification of new prognostic factors may enhance our understanding of the biologic behavior of early invasive cancer of the cervix. Our findings suggest that CD44v6 and MMP-1 may be markers worth further investigation in patients with microinvasive cervical cancer. (C) 2003 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:443 / 445
页数:3
相关论文
共 10 条
  • [1] Prognostic value of p53 expression in stage IB1 cervical carcinoma
    Chen, HY
    Hsu, CT
    Lin, WC
    Tsai, HD
    Chang, WC
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2000, 49 (04) : 266 - 271
  • [2] The possible role of p53 and bcl-2 expression in cervical carcinomas and their premalignant lesions
    Dimitrakakis, C
    Kymionis, G
    Diakomanolis, E
    Papaspyrou, I
    Rodolakis, A
    Arzimanoglou, I
    Leandros, E
    Michalas, S
    [J]. GYNECOLOGIC ONCOLOGY, 2000, 77 (01) : 129 - 136
  • [3] Early invasive (FIGO stage IA) carcinoma of the cervix: a clinico-pathologic study of 476 cases
    Elliott, P
    Coppleson, M
    Russell, P
    Liouros, P
    Carter, J
    Macleod, C
    Jones, M
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (01) : 42 - 52
  • [4] *FIGO, 2001, J EPIDERM BIOSTAT, V6, P5
  • [5] Expression of vascular endothelial growth factor (VEGF) and its mRNA in uterine cervical cancers
    Fujimoto, J
    Sakaguchi, H
    Hirose, R
    Ichigo, S
    Tamaya, T
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 (5-6) : 827 - 833
  • [6] MORRIS M, 1996, J NATL CANC I MONOGR, V21, P47
  • [7] Moser PL, 1999, ANTICANCER RES, V19, P4391
  • [8] The significance of erb-b2 immunostaining in cervical cancer
    Nevin, J
    Laing, D
    Kaye, P
    McCulloch, T
    Barnard, R
    Silcocks, P
    Blackett, T
    Paterson, M
    Sharp, F
    Cruse, P
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 73 (03) : 354 - 358
  • [9] MICRO-INVASIVE SQUAMOUS-CELL CARCINOMA OF THE CERVIX - A CLINICOPATHOLOGICAL STUDY OF 200 CASES WITH LONG-TERM FOLLOW-UP
    OSTOR, AG
    ROME, RM
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 1994, 4 (04) : 257 - 264
  • [10] Speiser P, 1999, INT J GYNECOL CANCER, V9, P160